Suppr超能文献

The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.

作者信息

Canonico Mario Enrico, Siciliano Roberta, Scudiero Fernando, Sanna Giuseppe Damiano, Parodi Guido

机构信息

Clinical and Interventional Cardiology, Sassari University Hospital, Sassari, Italy.

Department of Cardiology, ASST Bergamo Est, Seriate, Italy.

出版信息

Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):262-264. doi: 10.1093/ehjcvp/pvaa048.

Abstract
摘要

相似文献

1
The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):262-264. doi: 10.1093/ehjcvp/pvaa048.
2
Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.
Thromb Haemost. 2020 Aug;120(8):1233-1236. doi: 10.1055/s-0040-1712918. Epub 2020 May 26.
3
COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept.
Anaesth Crit Care Pain Med. 2020 Jun;39(3):381-382. doi: 10.1016/j.accpm.2020.04.013. Epub 2020 May 4.
5
COVID-19 Coagulopathy: Considerations for Urologists.
J Urol. 2020 Oct;204(4):640-641. doi: 10.1097/JU.0000000000001144. Epub 2020 May 18.
6
Thromboinflammatory response in SARS-CoV-2 sepsis.
Med Leg J. 2020 Jul;88(2):78-80. doi: 10.1177/0025817220926915. Epub 2020 Jun 3.
7
Problems related with anticoagulant usage during COVID-19 outbreak.
J Vasc Surg Venous Lymphat Disord. 2020 Jul;8(4):695-696. doi: 10.1016/j.jvsv.2020.04.022. Epub 2020 May 12.
8
Arterial thrombosis and coronavirus disease 2019 in a patient with cancer.
Eur J Cancer. 2020 Jul;134:1-2. doi: 10.1016/j.ejca.2020.05.002. Epub 2020 May 18.
9
Anticoagulants and immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS.
Ann Card Anaesth. 2020 Jul-Sep;23(3):258-259. doi: 10.4103/aca.ACA_126_20.
10
Hospital-based use of thromboprophylaxis in patients with COVID-19.
Lancet. 2020 May 2;395(10234):e75. doi: 10.1016/S0140-6736(20)30926-0. Epub 2020 Apr 21.

引用本文的文献

2
Heart failure during the COVID-19 pandemic: clinical, diagnostic, management, and organizational dilemmas.
ESC Heart Fail. 2022 Dec;9(6):3713-3736. doi: 10.1002/ehf2.14118. Epub 2022 Sep 16.
3
COVID-19 and coagulopathy.
Clin Respir J. 2021 Dec;15(12):1259-1274. doi: 10.1111/crj.13438. Epub 2021 Aug 30.
4
Clinical conditions and echocardiographic parameters associated with mortality in COVID-19.
Eur J Clin Invest. 2021 Dec;51(12):e13638. doi: 10.1111/eci.13638. Epub 2021 Jul 20.
6
Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 Patients.
Cardiovasc Drugs Ther. 2022 Aug;36(4):705-712. doi: 10.1007/s10557-021-07194-y. Epub 2021 May 14.
8
Acute pulmonary embolism in COVID-19 patient: a case report of free-floating right heart thrombus successfully treated with fibrinolysis.
Eur Heart J Case Rep. 2020 Dec 28;5(1):ytaa388. doi: 10.1093/ehjcr/ytaa388. eCollection 2021 Jan.
9
Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?
Am J Cardiovasc Drugs. 2021 Jul;21(4):377-382. doi: 10.1007/s40256-020-00460-8. Epub 2020 Dec 14.
10
Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome.
Thromb Res. 2021 Feb;198:34-39. doi: 10.1016/j.thromres.2020.11.017. Epub 2020 Nov 17.

本文引用的文献

1
Chest CT Features of COVID-19 in Rome, Italy.
Radiology. 2020 Aug;296(2):E79-E85. doi: 10.1148/radiol.2020201237. Epub 2020 Apr 3.
2
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
3
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
4
Warfarin-antiretroviral interactions.
Ann Pharmacother. 2009 Feb;43(2):322-8. doi: 10.1345/aph.1L497. Epub 2009 Feb 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验